Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

Business / Technology


Our network sites seattletimes.com | Advanced

Microsoft Pri0

Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times reporter Sharon Chan.

E-mail Sharon| RSS feeds Subscribe | Blog Home| Brier Dudley's Blog

November 7, 2007 5:18 PM

Potential rival to Enbrel on the horizon

Posted by Angel Gonzalez

An experimental arthritis therapy known as golimumab showed promising results in a late-stage clinical study for the treatment of psoriatic arthritis, Johnson & Johnson unit Centocor and Schering-Plough said Wednesday. The data signals the potential appearance of a new rival to Enbrel, the best-selling treatment developed in Seattle by Immunex and now sold by Amgen.

The compound is designed to be administered less frequently than Enbrel and Abbott Laboratories' Humira (one injection a month, instead of one a week for Enbrel and one every two weeks for Humira). The therapy constitutes an "incremental improvement" over Enbrel and other similar drugs, said Dr. Philip Mease, chief of the Swedish Medical Center's Division of Rheumathology Research in Seattle. Dr. Mease served as an investigator in the trial.

Digg Digg | Newsvine Newsvine

Submit a comment

*Required Field



Type the characters you see in the picture above.

Recent entries

Jul 1, 08 - 11:45 AM
Microsoft buying natural-language search company Powerset

Jun 30, 08 - 05:16 PM
Report: Microsoft to cut Xbox 360 price ahead of big industry event

Jun 27, 08 - 03:52 PM
Gates send-off: Gates has had Ballmer's back from the beginning

Jun 27, 08 - 01:09 PM
Gates send-off: Photos

Jun 27, 08 - 11:48 AM
Gates send-off: Two guys and 90,000 employees

Advertising

Marketplace

Advertising

Advertising

Categories
Calendar

July

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    
Browse the archives

July 2008

June 2008

May 2008

April 2008

March 2008

February 2008

Bill Gates: His Legacy, His Future

Bill Gates

Bill Gates, who last week ended his full-time involvement with Microsoft, was often right. He made a career, a company and an industry by looking over the horizon.

From the tech blogosphere

More on Microsoft from the Seattle Times

Advertising

Buy a link here